Desoxyrhaponticin is a bioactive small molecule that inhibits intestinal glucose absorption and renal reabsorption, contributing to its in vivo anti-hyperglycemic effects. It also acts as a fatty acid synthase (FAS) inhibitor, suppressing FAS activity and expression in vitro in MCF-7 breast cancer cells, highlighting its potential in metabolic and oncology research.